Innate Pharma SA
IPHA1.800USD
-0.020-1.10%
收盘 11/06, 16:00（美东）报价延迟15分钟
165.88M总市值
--市盈率 TTM
关于 Innate Pharma SA 公司
Innate Pharma SA 是一家总部位于法国的生物制药公司，开发用于治疗癌症和炎症疾病的药物。该公司识别和描述候选药物、选择适应症并管理产品的临床前和临床开发。Innate Pharma 主要专注于开发用于治疗癌症以及治疗传染病和慢性炎症病理的新型治疗方案和单克隆抗体。该公司开发两类免疫疗法：免疫调节剂和细胞毒性抗体。该公司与百时美施贵宝合作开展 I 期癌症抗体计划，与 Novo Nordisk A/S 合作开展两项炎症治疗抗体计划。该公司通过抗 NKG2A 抗体开展业务，这是 Novo Nordisk 准备用于肿瘤学 II 期开发的免疫检查点抑制剂。它还与阿斯利康建立了多产品合作伙伴关系。
Innate Pharma SA简介
公司代码IPHA
公司名称Innate Pharma SA
上市日期Oct 31, 2006
CEOMr. Jonathan Elliot Dickinson
员工数量- -
证券类型Depository Receipt
年结日Oct 31
公司地址117 avenue de Luminy
城市MARSEILLE
上市交易所NASDAQ Global Select Consolidated
国家France
邮编13009
电话33430303030
网址https://www.innate-pharma.com/
公司代码IPHA
上市日期Oct 31, 2006
CEOMr. Jonathan Elliot Dickinson
Innate Pharma SA公司高管
名称
名称/职务
职务
持股
持股变动
Prof. Eric Vivier, Ph.D.
Prof. Eric Vivier, Ph.D.
Senior Vice President, Chief Scientific Officer, Member of the Leadership Team
Senior Vice President, Chief Scientific Officer, Member of the Leadership Team
--
--
Mr. Nicola Beltraminelli
Mr. Nicola Beltraminelli
Vice President, Chief Development Officer, Member of the Leadership Team
Vice President, Chief Development Officer, Member of the Leadership Team
--
--
Mr. Frederic Lombard
Mr. Frederic Lombard
Chief Financial Officer, Member of the Leadership Team
Chief Financial Officer, Member of the Leadership Team
--
--
Mr. Gilles Brisson
Mr. Gilles Brisson
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. Henry Wheeler
Mr. Henry Wheeler
Vice President - Investor Relations and Communications, Member of the Leadership Team
Vice President - Investor Relations and Communications, Member of the Leadership Team
--
--
Ms. Odile Belzunce
Ms. Odile Belzunce
Vice President - Compliance, IT and Portfolio Management, Member of the Leadership Team
Vice President - Compliance, IT and Portfolio Management, Member of the Leadership Team
--
--
Mr. Olivier Martinez
Mr. Olivier Martinez
Member of the Supervisory Board, Representative of Bpifrance Participations
Member of the Supervisory Board, Representative of Bpifrance Participations
--
--
Ms. Claire De Saint-blanquat
Ms. Claire De Saint-blanquat
Vice President - Legal and Corporate Affairs, Secretary of the Supervisory Board, Member of the Leadership Team
Vice President - Legal and Corporate Affairs, Secretary of the Supervisory Board, Member of the Leadership Team
--
--
Dr. Sally Bennett
Dr. Sally Bennett
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Veronique Chabernaud, M.D.
Ms. Veronique Chabernaud, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Prof. Eric Vivier, Ph.D.
Prof. Eric Vivier, Ph.D.
Senior Vice President, Chief Scientific Officer, Member of the Leadership Team
Senior Vice President, Chief Scientific Officer, Member of the Leadership Team
--
--
Mr. Nicola Beltraminelli
Mr. Nicola Beltraminelli
Vice President, Chief Development Officer, Member of the Leadership Team
Vice President, Chief Development Officer, Member of the Leadership Team
--
--
Mr. Frederic Lombard
Mr. Frederic Lombard
Chief Financial Officer, Member of the Leadership Team
Chief Financial Officer, Member of the Leadership Team
--
--
Mr. Gilles Brisson
Mr. Gilles Brisson
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. Henry Wheeler
Mr. Henry Wheeler
Vice President - Investor Relations and Communications, Member of the Leadership Team
Vice President - Investor Relations and Communications, Member of the Leadership Team
--
--
Ms. Odile Belzunce
Ms. Odile Belzunce
Vice President - Compliance, IT and Portfolio Management, Member of the Leadership Team
Vice President - Compliance, IT and Portfolio Management, Member of the Leadership Team
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 10月16日 周四
更新时间: 10月16日 周四
持股股东
股东类型
持股股东
持股股东
占比
AllianceBernstein L.P.
0.07%
Morgan Stanley & Co. International Plc
0.06%
Citadel Advisors LLC
0.03%
Millennium Management LLC
0.01%
其他
99.84%
持股股东
持股股东
占比
AllianceBernstein L.P.
0.07%
Morgan Stanley & Co. International Plc
0.06%
Citadel Advisors LLC
0.03%
Millennium Management LLC
0.01%
其他
99.84%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
0.07%
Research Firm
0.06%
Hedge Fund
0.04%
其他
99.83%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
19
159.42K
0.17%
-86.66K
2025Q2
17
157.41K
0.17%
-54.22K
2025Q1
22
261.37K
0.29%
-22.81K
2024Q4
23
278.64K
0.34%
-188.16K
2024Q3
25
406.53K
0.50%
-579.77K
2024Q2
27
405.72K
0.50%
-529.94K
2024Q1
29
344.92K
0.22%
-517.69K
2023Q4
32
202.70K
0.25%
-1.13M
2023Q3
36
377.53K
0.47%
-1.02M
2023Q2
36
293.58K
0.36%
-1.21M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
AllianceBernstein L.P.
60.75K
0.07%
+36.48K
+150.33%
Jun 30, 2024
Morgan Stanley & Co. International Plc
51.22K
0.06%
+7.70K
+17.69%
Jun 30, 2025
Citadel Advisors LLC
26.62K
0.03%
+2.35K
+9.68%
Jun 30, 2025
Millennium Management LLC
11.66K
0.01%
-3.67K
-23.91%
Jun 30, 2025
UBS Financial Services, Inc.
5.96K
0.01%
-3.04K
-33.82%
Jun 30, 2025
GAMMA Investing LLC
2.28K
0%
-1.18K
-34.00%
Sep 30, 2025
Rhumbline Advisers Ltd. Partnership
470.00
0%
-205.00
-30.37%
Jun 30, 2025
Barclays Bank PLC
307.00
0%
--
--
Jun 30, 2025
Optiver Holding B.V.
101.00
0%
--
--
Jun 30, 2025
Tower Research Capital LLC
--
0%
-3.00
-100.00%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
ActivePassive International Equity ETF
0%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
ActivePassive International Equity ETF
占比0%
DFA Dimensional Intl Sustainability Core 1 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
